Tag: acute agitation and aggression treatment market demand

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Acute Agitation And Aggression Treatment Global Market Report 2024 Market from 2024 to 2033?

The acute agitation and aggression treatment market has shown strong growth in recent years. It will increase from $5.4 billion in 2023 to $5.72 billion in 2024, with a CAGR of 5.9%. Advances in pharmacology, a rise in clinical research, regulatory approvals, and an increase in cases of acute agitation and aggression are contributing factors.

The acute agitation and aggression treatment market is expected to grow, reaching $7.23 billion by 2028 at a CAGR of 6.0%. This growth is fueled by the aging population, expanding healthcare infrastructure, increasing pharmaceutical industry investments, home-based care, and higher disposable incomes. Trends include non-pharmacological interventions, precision medicine, AI and predictive analytics, community-based support, and industry collaborations.

Claim Your Free Sample of the Global Acute Agitation And Aggression Treatment Global Market Report 2024 Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=13078&type=smp

What Key Factors Are Fueling the Growth of the Acute Agitation And Aggression Treatment Global Market Report 2024 Market?

The increase in the incidence of dementia is expected to drive the growth of the acute agitation and aggression treatment market. The Australian Institute of Health and Welfare projects an increase in Australians with dementia from 401,300 in 2022 to an anticipated 849,300 in 2058. This rise in dementia cases is a key factor driving the growth of the acute agitation and aggression treatment market in the forecast period.

What Are the Major Segments of the Acute Agitation And Aggression Treatment Global Market Report 2024 Market?

1) By Treatment Approach: Behavioral Approaches, Environmental Interventions, Pharmacologic Approaches

2) By Drug Class: Anti-Psychotics, Benzodiazepines, Other Drug Classes

3) By Route of Administration: Oral, Intramuscular, Other Routes of Administrations

4) By Indication: Schizophrenia, Dementia, Bipolar Disorder, Depression, Drug-Induced Agitation And Aggression, Alcohol Withdrawal, Other Indications

5) By End User: Hospitals And Ambulatory Surgical Centers, Psychiatric Care Facilities, Other End Users

What New Trends Are Transforming the Acute Agitation And Aggression Treatment Global Market Report 2024 Market?

In the acute agitation and aggression treatment market, major companies like BioXcel Therapeutics are introducing innovative products. IGALMI (dexmedetomidine), approved in April 2022, offers a rapid treatment option for agitation associated with certain mental health disorders, working within minutes and lasting for about two hours.

Order Now for Fast Delivery of Your Acute Agitation And Aggression Treatment Global Market Report 2024 Market Report!

https://www.thebusinessresearchcompany.com/report/acute-agitation-and-aggression-treatment-global-market-report

Which Regions Are Driving Growth in the Acute Agitation And Aggression Treatment Global Market Report 2024 Market?

North America was the largest region in the acute agitation and aggression treatment market in 2023 . Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute agitation and aggression treatment market market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The Acute Agitation And Aggression Treatment Global Market Report 2024 Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the acute agitation and aggression treatment global market report 2024 market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Acute Agitation And Aggression Treatment Global Market Report 2024 Market Include

1. Acute Agitation And Aggression Treatment Global Market Report 2024 Market Executive Summary

2. Acute Agitation And Aggression Treatment Global Market Report 2024 Market Segments

3. Acute Agitation And Aggression Treatment Global Market Report 2024 Market Size And Template Market Growth Rate

4. Key Acute Agitation And Aggression Treatment Global Market Report 2024 Market Trends

5. Major Acute Agitation And Aggression Treatment Global Market Report 2024 Market Drivers

……

25. Key Mergers And Acquisitions In The Acute Agitation And Aggression Treatment Global Market Report 2024 Market

26. Top Acute Agitation And Aggression Treatment Global Market Report 2024 Companies

27. Acute Agitation And Aggression Treatment Global Market Report 2024 Market Opportunities And Strategies

28. Acute Agitation And Aggression Treatment Global Market Report 2024 Market, Conclusions And Recommendations

29. Appendix

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

 

The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies. 

The acute agitation and aggression treatment market has witnessed robust growth, escalating from $5.4 billion in 2023 to $5.72 billion in 2024, with a compound annual growth rate (CAGR) of 5.9%. This trajectory is fueled by advances in pharmacology, increased clinical research, regulatory approvals, a rise in the prevalence of acute agitation and aggression cases, and heightened awareness regarding mental health.

Anticipating Continued Growth: A Look into the Future The market is poised for sustained growth, with projections estimating an increase to $7.23 billion in 2028, exhibiting a CAGR of 6.0%. The forthcoming surge is attributed to factors such as a growing aging population, expanding healthcare infrastructure, increased pharmaceutical industry investment, a rise in home-based care, and an overall increase in disposable income.

Dementia Incidence: A Driving Force in Market Expansion

• Dementia’s Impact:The increase in dementia cases propels the growth of the acute agitation and aggression treatment market.
• Behavioral Manifestations:Agitation, a common symptom in dementia, necessitates effective treatment for improved patient quality of life.
• Projected Australian Statistics:In 2022, an estimated 401,300 Australians had dementia, with projections indicating a potential doubling by 2058.

Major Players Shaping the Landscape

• Key Market Players:Pfizer Inc., Johnson & Johnson Pvt Ltd., F Hoffmann-La Roche Ltd., and others contribute to market growth.
• Diverse Portfolio:Companies like AbbVie Inc., Novartis AG, Sanofi SA, and Bristol-Myers Squibb Company address various facets of acute agitation and aggression treatment.

Innovation Spotlight: Sublingual Film IGALMI (Dexmedetomidine)

• Groundbreaking Treatment:IGALMI (dexmedetomidine) is a sublingual film offering a novel approach to treating acute agitation associated with schizophrenia or bipolar disorder.
• Quick-Acting Solution:BioXcel Therapeutics Inc.’s product starts working within minutes and has a short duration of around 2 hours.
• FDA Approval:In April 2022, the Food and Drug Administration approved IGALMI, showcasing the industry’s commitment to advancing treatment options.

Strategic Acquisitions: SK Capital Partners and Apotex Inc.

• Acquisition Overview:In April 2023, SK Capital Partners LP acquired Apotex Inc., a Canada-based generic pharmaceutical producer, for an undisclosed amount.
• Market Expansion:SK Capital’s acquisition of Apotex aims to expand its presence in the generic pharmaceutical market and strengthen its overall investment in healthcare.

Market Segmentation: Understanding the Dynamics The acute agitation and aggression treatment market is segmented to provide a comprehensive understanding of its intricate dynamics.

1. By Treatment Approach:
   • Behavioral Approaches
   • Environmental Interventions
   • Pharmacologic Approaches
2. By Drug Class:
   • Anti-Psychotics
   • Benzodiazepines
   • Other Drug Classes
3. By Route of Administration:
   • Oral
   • Intramuscular
   • Other Routes of Administrations
4. By Indication:
   • Schizophrenia
   • Dementia
   • Bipolar Disorder
   • Depression
   • Drug-Induced Agitation And Aggression
   • Alcohol Withdrawal
   • Other Indications
5. By End User:
   • Hospitals And Ambulatory Surgical Centers
   • Psychiatric Care Facilities
   • Other End Users

Regional Dynamics: North America Leading, Asia-Pacific Rising

• North America:Emerged as the largest region in the acute agitation and aggression treatment market in 2023.
• Asia-Pacific:Anticipated to be the fastest-growing region in the forecast period, signaling a shift in global healthcare dynamics.

Conclusion: Steering Toward a Transformed Future As the acute agitation and aggression treatment market advances, it not only witnesses substantial growth but also undergoes significant transformations. The intersection of innovative treatments, strategic acquisitions, and a comprehensive market segmentation approach shapes the future of mental health treatment. With major players at the helm, technological advancements, and a growing awareness of mental health, the market is set to play a crucial role in enhancing the quality of life for those affected by acute agitation and aggression.

View More On The Acute Agitation And Aggression Treatment Market Report 2024 – https://www.thebusinessresearchcompany.com/report/acute-agitation-and-aggression-treatment-global-market-report

Request A Sample Of The Global Acute Agitation And Aggression Treatment Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=13078&type=smp